Overview
A two-peptide blend pairing KPV (a strong anti-inflammatory, especially for gut/skin) with GHK-Cu (the copper repair peptide).
Together they target inflammation and tissue repair, useful for gut issues, skin healing, and inflamed connective tissue.
What It Does
KPV (the C-terminal tripeptide of α-MSH) is a potent anti-inflammatory that calms NF-κB signaling, notable for gut (IBD-type) and skin inflammation.
GHK-Cu drives copper-dependent tissue repair, collagen synthesis, and angiogenesis.
The blend combines “calm the inflammation” with “rebuild the tissue.” This vial is KPV 10 mg + GHK-Cu 50 mg (60 mg total).
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 60 mg (KPV 10 + GHK-Cu 50) | + 3 mL | 20 mg/mL blend |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Weeks 1–2 | Daily | 1 mg | SubQ. Delivers ~167 mcg KPV + ~833 mcg GHK-Cu. Assess tolerance. |
| Weeks 3–6 | Daily | 2 mg | Working dose (~333 mcg KPV + ~1.7 mg GHK-Cu). |
| Off | 2–4 weeks | – | Standard washout; re-cycle if needed. |
4–6 weeks on / 2–4 weeks off.
daily, anytime; SubQ near the area of need for local effect, or abdomen for systemic. Note: both components are injectable here (KPV is given SubQ, not oral); the blend targets gut/skin inflammation plus repair.
Unisex (anti-inflammatory + copper repair), same protocol for men and women, no cycle effect. Avoid in pregnancy.
Handling & Stacking
- Freeze-dried: -4°F.
- Reconstituted: 36–46°F, protect from light.
- Best used within about 2–4 weeks, kept cold and dark (structure-based estimate, no published data); copper oxidizes with no visible colour change, so use it sooner rather than later.
- Reduced inflammation (gut/skin) plus tissue-repair support over 4–6 weeks.
- Good for inflamed, healing tissue where both actions help.
- Supply math 60mg → 5 vials (6-wk @ 2 mg blend × 7/wk)
Safety & Patient Education
- Active or suspected malignancy.
- Copper is an angiogenesis cofactor, so GHK-Cu carries the same theoretical concern, though this blend has no BPC- 157 or TB-500 and KPV carries no growth signal.
- Stop for any new lump.
- Wilson’s disease / copper overload (GHK-Cu component) Pregnancy and lactation Hypersensitivity to either component
- hsCRP (inflammation) baseline + end if treating inflammation Serum copper/ceruloplasmin if used long-term or high-dose Out of range?
- Rising serum copper / ceruloplasmin = copper is accumulating → pause and re-dose lower.
